Scilex Holding Company (SCLX) is in Healthcare, Drug Manufacturers - General, based in United States, listed on NasdaqCM. Market cap 20.82M USD. 52-week range 2.62 to 16.81 USD. Data as of 2026-10-09.
Scilex Holding Company focuses on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. Its commercial products include ZTlido (lidocaine topical system) 1.8% (ZTlido), a prescription lidocaine topical product for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a ready-to-use oral solution for the acute treatment of migraine with or without aura ...